EN DE

MGRB Fair Value & Analysis

US · Market cap $6.3B

M MGRB logo MGRB MGRB · US
Price$16.46
Fair Value$26.47
Upside+60.8%
Quality82/100
Watch MGRB for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 0.0% net margin
Moderate debt · generates free cash flow
6.99% dividend yield
Wide moat 71/100
Evidence: Medium Range $18.49 – $34.45 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated today

Fair value updated Aug 13, 2026, revised from $27.38 to $26.47 (−3.3%) since Jul 18, 2026. Share price −2.1% over the past month.

A strong business, screening 61% undervalued on our models.

What matters now

  • The rarer combination: high quality (82/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case ($18.49). The market is more pessimistic than our downside scenario.
  • A fairly wide model range ($18.49 to $34.45) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$19.96 $13.20 Fair Value $26.47 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $13.20 – $19.96 · fair‑value band $18.49 – $34.45 · the $16.46 price screens below the $26.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

MGRB (MGRB) currently trades at $16.46, while our model-based Fair Value estimate is $26.47, implying the stock looks roughly 60.8% undervalued today. The Quality Score stands at 82/100 (high quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

It earns a return on equity of 13.1%. Net debt stands at $2.1B. Fundamentals as of Aug 13, 2026

Our scenario range runs from $18.49 (bear case) to $34.45 (bull case); at $16.46, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 9% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $22.98 $34.97 $51.18 80
Residual Income $12.22 $17.75 $109.09 76
Rev-Margin DCF $11.70 $18.76 $26.86 74
All 26 models by family
DCF Models
FCF DCF $22.49 $35.92 $55.16 38
Owner Earnings $19.10 $30.88 $47.75 31
5Y Revenue Exit $11.70 $18.38 $26.47 39
5Y EBITDA Exit $18.45 $30.80 $44.83 41
5Y P/E Exit $20.64 $34.83 $49.39 38
10Y Revenue Exit $15.21 $22.08 $30.55 36
10Y EBITDA Exit $19.71 $30.44 $44.03 37
10Y P/E Exit $21.07 $33.15 $47.38 35
Earnings-Based
Graham-Dodd $12.63 $36.17 $47.69 54
Lynch FV $7.42 $10.60 $13.79 50
PEG = 1.0 $7.42 $10.60 $13.79 46
EPV $6.60 $8.44 $10.03 59
Dividend Discount
Gordon GGM $0.0200 $0.0500 $0.0700 70
DDM Multi-Stage $0.0200 $0.0400 $0.0500 61
Multiples
P/E Multiple $27.86 $37.14 $46.43 63
P/S Multiple $11.88 $15.85 $19.81 58
P/B Multiple $18.88 $25.18 $31.47 55
EV/EBIT $22.13 $31.18 $40.24 53
EV/EBITDA $18.89 $26.87 $34.85 54
EV/Revenue $6.04 $10.79 $15.55 43
Asset-Based
NCAV (Graham) $4.20 $5.62 $8.39 50
Growth DCF
Growth DCF $22.98 $34.97 $51.18 80
Rev-Margin DCF $11.70 $18.76 $26.86 74
Economic Profit
Residual Income $12.22 $17.75 $109.09 76
ROIC Compounder $6.60 $8.46 $11.41 72
Growth Earnings
Growth-Adj P/E $22.50 $32.15 $41.79 68

Widest divergence: Growth Earnings ($32.15) versus Dividend Discount ($0.0400). Highest evidence: Growth DCF (80).

Notify me when MGRB reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Return on equity 13.1%
Free cash flow $1.0B FY2025
Dividend yield 7.0%
Net debt $2.1B FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 82/100

Of which business quality 76 · Market factors (momentum, volatility) 55

Profitability 57
Margins and returns on capital today
Quality Growth 84
Are margins and returns improving?
Cashflow 90
Earnings quality: real cash, not paper profit
Fin. Strength 48
Balance sheet, leverage, solvency risk
Investment 98
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 38
Price trend over the last 3–12 months (market factor)
52W Momentum 33
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

MGRB reported revenue of $2.4B in FY2025 versus $2.4B in FY2021, a compound +0.3%/yr. Reported net income was $717M in FY2025, compounding +6.1%/yr from FY2021.

Growth Quality 71/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$2.4B
Latest YoY
+19.8%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.8%
Avg. growth/yr (29Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+14.3%
Revenue +0.3%/yr
FY21 $2.4B
FY22 $2.3B
FY23 $2.1B
FY24 $2.0B
FY25 $2.4B
Net income +6.1%/yr
FY21 $566M
FY22 $1.1B
FY23 $673M
FY24 $512M
FY25 $717M
Character of growth · EPS growth decomposed (2014-2025) +8.5 % p.a.
Revenue per share +3.9 pp

of which total revenue −1.0 pp · buybacks/dilution +4.9 pp

EBIT margin −0.9 pp
Tax rate +1.3 pp
Residual (interest, one-offs) +4.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch MGRB: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "MGRB Fair Value". https://www.fairvalue-calculator.com/stock/MGRB

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 0
FUTURE 0 · sector 0
PAST 52 · sector 0
HEALTH 61 · sector 0
DIVIDEND 100 · sector 0

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is MGRB overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $26.47 versus a price of $16.46, about +61% (undervalued).
What is the fair value of MGRB?
Our model-based fair value for MGRB is $26.47 (as of Aug 13, 2026), built from audited fundamentals. The current price is $16.46.
What is the quality score of MGRB?
MGRB has a Quality Score of 82/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the net profit margin of MGRB?
The net profit margin of MGRB is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.
Does MGRB pay a dividend?
MGRB currently shows a dividend yield of about 6.99% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track MGRB and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.